Topic: thrombocytopenia

Tavalisse

7. Tavalisse

Tavalisse has had a bumpy road but is now green-lighted to treat thrombocytopenia in adult patients with ITP, a rare disease that causes the immune system to attack and destroy platelets.
FDA

13. Doptelet

Doptelet, Dova’s first commercial product, is approved to boost platelet count in patients with chronic liver disease ahead of surgery so that they don’t have to undergo risky blood transfusions.